cancer immunotherapy

You have access
Methods for monitoring cancer cell pyroptosis
Shuo Wang, Yuantong Liu, Lu Zhang and Zhijun Sun

Cancer Biology & Medicine April 2022, 19 (4) 398-414; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0504
You have access
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
Yungang Wang, Shouyan Deng and Jie Xu

Cancer Biology & Medicine August 2020, 17 (3) 583-598; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0066
You have access
Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment
Yuting Zhang, Liu Guoqiang, Miaomiao Sun and Xin Lu

Cancer Biology & Medicine February 2020, 17 (1) 32-43; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0372
You have access
Current applications and future prospects of nanotechnology in cancer immunotherapy
Sen Yan, Peng Zhao, Tingting Yu and Ning Gu

Cancer Biology & Medicine August 2019, 16 (3) 486-497; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0493
You have access
PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy
Long Jia, Qi Zhang and Rongxin Zhang

Cancer Biology & Medicine May 2018, 15 (2) 116-123; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0086

Main menu